U0126: Not only a MAPK kinase inhibitor
- PMID: 36091807
- PMCID: PMC9452634
- DOI: 10.3389/fphar.2022.927083
U0126: Not only a MAPK kinase inhibitor
Abstract
U0126, as an inhibitor of the MAPK signaling pathway, is closely related to various biological processes, such as differentiation, cell growth, autophagy, apoptosis, and stress responses. It makes U0126 play an essential role in balancing cellular homeostasis. Although U0126 has been suggested to inhibit various cancers, its complete mechanisms have not been clarified in cancers. This review summarized the most recent and relevant research on the many applications of U0126 and described its role and mechanisms in different cancer cell types. Moreover, some acknowledged functions of U0126 researched in the laboratory were listed in our review. We discussed the probability of using U0126 to restain cancers or suppress the MAPK pathway as a novel way of cancer treatment.
Keywords: MAPK inhibitors; MAPK signal pathway; U0126; cancer; cancer therapy.
Copyright © 2022 You, Niu, Zhang, Huang, Ding, Sun and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Baines P., Fisher J Fau - Truran L., TruranFau - Davies L. E., Davies E Fau - Hallett M., Hallett M Fau - Hoy T., Hoy T Fau - Burnett A. K., et al. (2002). The MEK inhibitor, PD98059, reduces survival but does not block acute myeloid leukemia blast maturation in vitro . Eur. J. Haematol. 64, 211–218. 10.1034/j.1600-0609.2000.90139.x - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
